Delivery Order SPE2DB22D2206-SPE2DB24FGU39
Award Date 4/22/24
Potential Completion Date 4/23/24
Potential Value $16K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,529,542 units of Ketorolac 15 mg/ml vial. The $1,072.43 delivery order contract has a firm fixed price pricing type and a completion date of May 8, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ketorolac 30 mg/mL vials. The $3,134.03 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, which has no set-aside designation, has an ultimate completion date of July 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery Contract...
- This federal contract award is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,357.72, is a firm fixed-price delivery order for the supply of Ketorolac 30 mg/mL vials. The contract has a period of performance through June 13, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the supply of 4564756176 KETOROLAC 30 MG/ML VIALML to the Defense Logistics Agency (DLA). The contract, valued at $1,406.10, is a Firm Fixed Price Delivery Order with a completion date of May 31, 2024. This award is not associated with a set-aside designation. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award for the delivery of Ketorolac 30 mg/ml vials to the U.S. Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The contract has a ceiling value of $2,493.63 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Ketorolac 30 mg/ml vials, a prescription medication. The contract has a ceiling value of $1,326.96 and is a firm-fixed-price delivery order with a completion date of May 28, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a substantial Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the delivery of Ketorolac 30 mg/ml vials. The award has a fixed-price delivery order contract type with a ceiling value of $2,287.60 and an ultimate completion date of May 31, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $3,600.88 firm fixed-price delivery order is for the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2025 and was competitively awarded with no set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,384.85 Firm Fixed Price Delivery Order is for the supply of Ketorolac 30 mg/ml vial, a non-steroidal anti-inflammatory drug, with a completion date of June 11, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,172.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,808,700 units of the medication Ketorolac 60 mg/2 ml vial. The contract has a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is likely part of a larger indefinite delivery contract (IDC) valued at up to...